Assessment of Salvage Regimens Post-Chimeric Antigen Receptor T Cell Therapy for Patients with Diffuse Large B Cell Lymphoma

Sigmund, AM; Denlinger, N; Huang, Y; Bond, D; Voorhees, T; Bajwa, A; Elder, P; Brammer, JE; Saad, A; Penza, S; Vasu, S; de Lima, M; Jaglowski, S; Kittai, AS

Kittai, AS (通讯作者)，Ohio State Univ, Dept Internal Med, Div Hematol, 1140D Lincoln Tower,1800 Cannon Dr, Columbus, OH 43210 USA.

TRANSPLANTATION AND CELLULAR THERAPY, 2022; 28 (6):

Abstract

Anti-CD19 chimeric antigen receptor T cell therapy (CAR19) represents a critical treatment modality for patients with relapsed/refractory (R/R) diffus......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索